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Abstract
Background Biofilm-associated infections in trauma sur-
gery are difficult to treat with conventional therapies.
Therefore, it is important to develop new treatment
modalities. Maggots in captured bags, which are permeable
for larval excretions/secretions, aid in healing severe,
infected wounds, suspect for biofilm formation. Therefore
we presumed maggot excretions/secretions would reduce
biofilm formation.
Questions/purposes We studied biofilm formation of
Staphylococcus aureus, Staphylococcus epidermidis,
Klebsiella oxytoca, Enterococcus faecalis, and Enterobac-
ter cloacae on polyethylene, titanium, and stainless steel.
We compared the quantities of biofilm formation between
the bacterial species on the various biomaterials and the
quantity of biofilm formation after various incubation
times. Maggot excretions/secretions were added to existing
biofilms to examine their effect.
Methods Comb-like models of the biomaterials, made to
fit in a 96-well microtiter plate, were incubated with bac-
terial suspension. The formed biofilms were stained in
crystal violet, which was eluted in ethanol. The optical
density (at 595 nm) of the eluate was determined to
quantify biofilm formation. Maggot excretions/secretions
were pipetted in different concentrations to (nonstained)
7-day-old biofilms, incubated 24 hours, and finally measured.
Results The strongest biofilms were formed by S. aureus
and S. epidermidis on polyethylene and the weakest on
titanium. The highest quantity of biofilm formation was
reached within 7 days for both bacteria. The presence of
excretions/secretions reduced biofilm formation on all
biomaterials. A maximum of 92% of biofilm reduction was
measured.
Conclusions Our observations suggest maggot excre-
tions/secretions decrease biofilm formation and could
provide a new treatment for biofilm formation on infected
biomaterials.
Introduction
Infections of medical prosthetic devices in trauma and
orthopaedic surgery are difficult to treat with conventional
therapies like antibiotics and surgery [7], and can lead to
severe consequences, such as removal of the implant with
functional loss of the affected limb [18, 26]. The most
frequently isolated bacteria causing these implant- and
patient-related infections are S. aureus and the coagulase-
negative S. epidermidis [1, 11]. Less common are Pseu-
domonas aeruginosa, Klebsiella oxytoca, Enterococcus
faecalis, and Enterobacter cloacae. In prosthesis-associated
infections, the causative bacteria form biofilms composed
mainly of a polysaccharide matrix [8]. The most important
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difference between bacteria in biofilms and planktonic
microorganisms that can explain the alteration in antibiotic
resistance is the metabolic state of biofilm bacteria [24].
The genotype and phenotype of bacteria in biofilms and the
protein expression are altered and the oxygen concentration
in biofilms is limited [3]. These changes result in metabolic
quiescence, which could be overcome by providing alter-
native electron acceptors of fermentable substrates [3, 24].
Current antimicrobial therapies frequently cannot ade-
quately treat biofilm-associated infections [8, 9, 24, 26]
and therefore it is important to develop new treat-
ment approaches to reduce biofilm formation (BF) on
biomaterials.
The most important development in the treatment of
infectious diseases during the last century was the dis-
covery of penicillin by Fleming in 1928 [29]. At
approximately the same time, maggot debridement therapy
(MDT) was introduced by William S. Baer, an orthopaedic
surgeon who worked at Johns Hopkins Hospital in Balti-
more, Maryland [2]. Baer used MDT to treat children with,
at that time, incurable osteomyelitis. Although Baer
showed the beneficial effects of maggots of the Lucilia
sericata, MDT essentially disappeared after the discovery
of penicillin, which could control numerous types of severe
infections [29]. Because of increasing antibiotic resistance
[15], larval therapy was reintroduced in the 1980s as a
treatment for severely infected wounds [21]. Maggots now
are used successfully in various patient clinics [13, 25]. In
2004, MDT was approved by the US Food and Drug
Administration (510[k] #33391) [27].
In our clinical practice, we use maggots captured in
small nylon bags, consisting of a 2-mm thin foam layer of
polyvinyl alcohol (Biobag1; BioMonde GmbH, Barsbu¨ttel,
Germany) [13]. These bags are able to permeate maggot
excretions and secretions (ES). We have observed healing
of wound infections suspect for BF using maggots in such
bags. In an earlier pilot study, we found ES reduced the
quantity of immature biofilms of P. aeruginosa [6]. How-
ever, the current research investigated, for the first time, the
influence of a range of concentrations of ES on mature
7-day-old biofilms formed by new, commonly isolated
bacterial species on different biomaterials. If maggot ES
reduce BF of bacteria that frequently are isolated from
biofilm-associated infections, ES could provide us with a
new treatment possibility.
Therefore, we asked (1) whether five bacterial species
(S. aureus, S. epidermidis, K. oxytoca, E. faecalis, and E.
cloacae), were able to form biofilms on polyethylene (PE),
titanium (TI), and/or surgical stainless steel (SSS), and if
so, whether (2) the quantity of BF differed among the
bacterial species, (3) the quantity of BF depended on the
biomaterial surface, and (4) the quantity of biofilms of
the biofilm-forming bacteria differed among 3, 5, 7, or
9 days of incubation time. Finally, we hypothesized (5)
sterile maggot ES could decrease the growth of the bac-
terial biofilms on the commonly used biomaterials SSS, TI,
and PE.
Materials and Methods
First, we investigated BF of five different, clinical isolated
species on comb-like models of PE, TI, and SSS sus-
pending in a 96-well microtiter plate with nutrient medium
and bacteria (Fig. 1) [6]. Two of the five tested bacterial
species formed visible biofilms that could be quantified and
these bacteria were used to investigate the second to fifth
research questions. The dependent variable in the second to
fifth research questions was the quantity of formed biofilm;
BF was compared among the two biofilm-forming species,
among the different biomaterials SSS, TI, and PE and
between various incubation times on Days 5, 7, and 9.
Finally, we determined the effect of maggot ES on BF
formation.
The custom-made, sterile comb-like models of regularly
available orthopaedic implant materials, consisting of eight
prongs were produced according to our design. These
models of SSS, TI, and PE (Litos GmbH, Hamburg,
Germany) were made to fit in a 96-well microtiter plate [6].
Each prong was considered one test and experiments were
performed at least 12 times.
S. aureus, S. epidermidis, K. oxytoca, E. faecalis, and
E. cloacae all were isolated from infected prosthetic devices
of patients in our clinic. BF was tested using a previously
described model [6]. Briefly, S. aureus and S. epidermidis
were grown overnight in tryptic soy broth (TSB) medium
(Becton, Dickinson & Co, Franklin Lakes, NJ) and K.
oxytoca, E. faecalis, and E. cloacae in brain heart infusion
(BHI) medium (Becton, Dickinson & Co) at 37C. A sta-
tionary phase culture was made in either TSB or BHI to a
density of McFarland 0.5 corresponding with 1.5 9 108
colony-forming units (CFUs) per lL. The inoculum was
controlled by inoculating nutrient agar plates (Biotrading
Benelux BV, Mijdrecht, The Netherlands) with 10-lL
volumes of serial 1:10 dilutions of the bacterial suspension
and counting the formed CFUs after incubation overnight at
37C.
The bacterial suspension was diluted to a final inoculum
of 2.5 9 105 bacteria per mL and a volume of 100 lL
of this suspension was pipetted into 24 wells of a sterile
96-well flat-bottomed microtiter plate (Greiner Bio-one
BV, Monroe, NC). One comb of each biomaterial was
placed in eight of the wells and four of these microtiter
plates with combs were incubated for 3, 5, 7, or 9 days at
37C to form biofilms on the devices. Control combs were
suspended in nutrient medium.
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After the incubation time, each comb was washed under
slow-running distilled water at room temperature for 30
seconds to remove planktonic cells. All comb models were
stained for 15 minutes with 1% crystal violet [6], based on
the methods of Pitts et al. [19] and Stepanovic et al. [23].
Each comb was suspended in eight wells of a new micro-
titer plate filled with 270 lL ethanol absolute to absorb the
crystal violet [19]. The plates were left for 48 hours at
room temperature to allow the stained biofilm bacteria to
elute with ethanol. All stained biofilm bacteria are soluble
1) Ability of BF by the bacteria was tested.  
7-day-old biofilms on PE, TI, and SSS  
were stained and, if possible, quantified.  
S. aureus  K. oxytoca 
S. epidermidis  E. faecalis 
   E. cloacae 
Formed visible biofilms that     
could be quantified.    Biofilms could not be quantified. 
No further testing. 
2) Comparison of quantity of BF  
among 7-day-old biofilms of 
S. aureus and S. epidermidis. 
Statistical analysis by Student’s T-test 
for independent variables: 
A comparison was made between the mean of the 7-day-old biofilm 
formed by S. aureus and the mean of the 7-day-old biofilm by S. 
epidermidis.  
3) Comparison of quantity of 7-day-old 
biofilms among PE, TI, and SSS. 
Statistical analysis by one-way ANOVA, 
followed by LSD post hoc test: 
A comparison was made between the mean of the quantities 
of 7-day-old biofilms formed on PE, TI,  
and SSS. 
4) Comparison of quantity of biofilm  
formed after 3, 5, 7, and 9 days. 
Statistical analysis by repeated measures ANOVA, 
followed by Bonferroni correction: 
A comparison was made between the mean of the quantities 
of biofilm at each time.  
5) Comparison of quantity of 7-day-old biofilms 
with and without presence of (different concentrations  
of) maggot ES.  
Inhibition of further biofilm growth was tested (compared with 8-day-old 
BF) and breakdown of existing biofilms (compared with 7-day-old BF).  
Statistical analysis by Student’s T test 
for independent variables: 
A comparison was made between the mean BF with ES (per 
concentration) and the mean of the 7-day-old BF and 8-
day-old BF without ES. 
Experiments for research questions 1 to 4 were performed in octuplicate.  
Experiments for research question 5 were performed in quadruplicate. 
Fig. 1 An overview of the study design
is shown. BF = biofilm formation;
PE = polyethylene; TI = titanium;
SSS = surgical stainless steel; ES =
excretions and secretions.
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in ethanol, however the biofilm on PE could not be eluted
entirely in ethanol (maximum time tested was 96 hours),
but we standardized the time of elution to 48 hours to
guarantee reliable interpretation of the results. After gentle
shaking of the microtiter plate, a volume of 150 lL of the
ethanol and crystal violet solution was pipetted into a new
plate and the optical density (OD) of this solution was
measured at a wavelength of 595 nm and is representative
for the quantity of biofilm formation [19]. Biofilms of each
bacterial species were formed at least in octuplicate, so that
one comb was tested with each of the eight prongs sus-
pended in a separate well with nutrient medium and
bacterial suspension.
Sterile maggot ES of Instar-3 larvae (BioMonde GmbH)
were collected as described previously [6]. Briefly, the
maggots were incubated in sterile tubes for 1 hour at 35C
in darkness. Then, ES were removed by pipette, divided in
aliquots, and stored at 80C. One ES pool was collected
from at least 1000 maggots, which resulted in approxi-
mately 1200 lL ES per hour. The protein concentration
was determined using the Pierce Bicinchoninic Acid Pro-
tein Assay kit (Pierce Biotechnology, Rockford, IL).
Absolute OD values of the control BF after 7 days
without ES are reported in Results. To compute absolute
and relative OD, we first subtracted the material-specific
background absorbance. The measured OD values of the
biofilm experiments were converted to percentages using
the following formula:
OD biofilmð Þ  100%½ =OD controlð Þ ð1Þ
where OD (biofilm) refers to either BF measured on Day 3,
5 or 9 (without ES) or BF measured after the addition of
increasing concentrations of ES and where OD (control) is
the BF after 7 days on the negative control prongs. In all
experiments, the 7-day-old biofilm without ES (the control)
was considered 100%.
Biofilms were allowed to form on 13 combs of each of
the materials for 7 days, two other combs were suspended
in nutrient medium without bacteria as negative controls
and represented the material-specific background absor-
bance. BF on two of the 13 combs was measured on Day 7.
Two other combs were suspended in a new microtiter plate
with medium and incubated another 24 hours to allow
additional growth of the biofilm (the 8-day-old biofilms);
nine combs were suspended in a logarithmic range of
concentrations of ES, diluted in nutrient medium: 0.31,
0.93, 2.78, 8.33, 25, and 75 lg ES per well. All wells were
incubated another 24 hours at 37C and then we quantified
the biofilm as described previously. This experiment
investigated possible biofilm inhibition and breakdown by
ES. Biofilm inhibition (or prevention) by ES was defined as
BF that was lower than 8-day-old biofilms which grew
further after Day 7. BF that was lower than 7-day-old BF
after incubation in ES was defined as biofilm breakdown.
Biofilm reduction is any effect of ES that results in less BF.
The first research question was not analyzed statistically
because the results were obtained by observation only. For
the second and the last research questions, Student’s t test
for independent groups was used. The means of the 7-day-
old biofilms of the biofilm-forming bacterial species were
compared to analyze whether BF depended on the bacterial
species. Furthermore, the mean BF with ES (per concen-
tration) and the mean of the 8-day-old biofilm without ES
were compared. For the third research question, one-way
ANOVA was used and followed by the least significance
difference post hoc test. All analyses met the assumption
of homogeneity of variances (Levene’s statistic: p [ 0.05).
To analyze whether the BF depended on the material sur-
face, the mean quantity of a 7-day-old biofilm was compared
among the materials for each bacterium. The mean quan-
tities of biofilms formed on Days 5, 7, and 9 for each bac-
terium were analyzed using repeated-measures ANOVA
followed by the Bonferroni correction to investigate
whether the BF changed among these 3 days. All analyses
met the assumption of sphericity (Mauchly’s test: p [ 0.05).
All statistical analyses were performed using SPSS1 for
Windows1, Version 14.0 (SPSS Inc, Chicago, IL).
Results
All tested bacterial species were able to form visible bio-
films on PE, SSS, and TI, however biofilms of K. oxytoca,
E. faecalis, and E. cloacae could barely be observed, in
contrast to the clearly visible biofilms of S. aureus and S.
epidermidis. Quantities of biofilm formed by K. oxytoca,
E. faecalis, and E. cloacae were insufficient to be mea-
sured. Therefore, we focused on BF by S. aureus and S.
epidermidis and continued the experiments with these two
bacterial species.
BF by S. aureus was determined and compared with BF
by S. epidermidis. No differences in quantity were seen on
PE (p = 0.582), SSS (p = 0.051), or TI (p = 0.178)
(Fig. 2).
BF by S. aureus was greater on PE (OD595 0.315) than
on SSS (OD595 0.190) (p = 0.024) and TI (OD595 0.0386)
(p \ 0.001) (Fig. 2A; Table 1) and the same trend was
seen for BF by S. epidermidis (PE: OD595 0.248, SSS:
OD595 0.104 [p \ 0.001]; TI: OD595 0.0578 [p \ 0.001])
(Fig. 2B; Table 2).
S. aureus and S. epidermidis were observed for BF
during 3, 5, 7, and 9 days. On Day 3, biofilms of both
bacteria occurred in insufficient quantity to be measured.
On TI, PE, and SSS, most biofilm was formed by S. aureus
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on Day 7 and Day 9 (Day 7 versus Day 9 [all p val-
ues C 0.198]) (Fig. 3A). The amount of biofilm formed by
S. epidermidis on PE was equal at all times of incubation
(Day 5 versus Day 7 [p = 1.000], Day 5 versus Day 9
[p = 0.074]) (Fig. 3B). On Day 7 and Day 9 the greatest
quantity of biofilms was formed by S. epidermidis on SSS
and TI (Day 7 versus Day 9 [all p values C 0.141])
(Fig. 3B).
The addition of ES to 7-day-old biofilms of S. aureus
and S. epidermidis reduced these biofilms compared with
biofilms without addition of ES on all tested biomaterials
(Figs. 4, 5). The biofilm of S. aureus on SSS and PE
decreased for all concentrations of ES to minimums of
40.5% on SSS for 0.31 lg ES per well (p \ 0.001) and
39.2% on PE for 0.93 lg ES per well (p \ 0.001) as
compared with the control biofilm without ES (Fig. 4A–B).
On TI, only 8.33 lg ES per well showed a reduction
(p = 0.005) of biofilm (Fig. 4C), but BF on TI was very
low overall. Biofilms of S. epidermidis formed on SSS
and PE also were reduced for all concentrations of ES
(Fig. 5A–B). Biofilms decreased to minimums of 32.3%
on SSS for 25 lg ES per well (p \ 0.001) and 7.6% on PE
for 8.33 lg ES per well (p \ 0.001) compared with the
control. On TI, concentrations of 0.31 lg ES per well
(p \ 0.001) and 0.93 lg ES per well (p = 0.021) showed
less biofilm (Fig. 5C).
Discussion
Biofilm-associated infections related to implants cannot be
treated easily and frequently the implanted device must be
removed with severe consequences for the patient. There-
fore, new approaches for these kinds of infections are
needed. Cazander et al. previously reported maggot ES
reduced BF of P. aeruginosa [6]. In the current study, we
investigated whether other bacterial species, namely,
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Fig. 2A–B The ODs reflect the quantities of 7-day-old biofilms
produced by (A) S. aureus and (B) S. epidermidis on PE, SSS, and TI
and answer the second and the third research questions, respectively,
whether the quantity of BF differed among S. aureus and S.
epidermidis and whether BF depended on the biomaterial surface.
Both bacteria formed equal quantities of BF and showed PE had the
highest BF followed by SSS and TI with the lowest quantity of
biofilm. *For these comparisons all p values \ 0.001.
Table 1. Optical density (595 nm) for a 7-day-old biofilm by
S. aureus
Material 7-day-old biofilm Background absorbance
Polyethylene 0.315 0.167
Surgical stainless steel 0.190 0.101
Titanium 0.0386 0.0801
Table 2. Optical density (595 nm) for a 7-day-old biofilm by
S. epidermidis
Material 7-day-old biofilm Background absorbance
Polyethylene 0.248 0.162
Surgical stainless steel 0.104 0.0800
Titanium 0.0578 0.0740
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Fig. 3A–B The graphs show the amount of BF after various
incubation times and answer the fourth research question, whether
quantity of biofilms differed among 3, 5, 7, or 9 days. The 7-day-old
BF was defined as 100%. (A) Biofilms by S. aureus kept on growing
until Day 9 on PE, TI, and SSS. (B) The largest amount of biofilm by
S. epidermidis was formed within 7 to 9 days on SSS and TI. The
amount of biofilm on PE was similar at all incubation times. *For
these comparisons all p values \ 0.001; all other comparisons were
similar.
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S. aureus, S. epidermidis, K. oxytoca, E. faecalis, and E.
cloacae, were able to form biofilms on PE, TI, and SSS,
and if so, whether the quantity of BF differed between the
bacterial species, whether the quantity of BF depended on
the biomaterial surface, and whether the largest amount of
BF was formed after 3, 5, 7, or 9 days. Finally, we
hypothesized sterile maggot ES could reduce BF on the
biomaterials.
Several limitations of the study must be noted. First, we
performed only a crystal violet assay as a standard method
to measure biofilms, but other methods could be used
in vitro [30] and in vivo [14]. We modified the crystal
violet assay to our design with the combs of PE, TI, and
SSS, however the assay was based on the commonly used
methods of Pitts et al. [19] and Stepanovic et al. [23].
Second, every experiment was performed with one pool
maggot ES, but we did not compare the effectiveness
between the various pools. The use of different pools will
not likely influence the conclusions of this research,
because in an earlier study, the effectiveness of ES was
compared and similar results of biofilm reduction occurred
using various pools of ES [6]. Our study conditions were
adapted as much as possible to those in clinical practice.
For example, ES were collected under standard conditions
in darkness, had an acidity of pH 8, and were incubated at
35C. Furthermore, the protein concentration from each
collected ES was measured to standardize the various
pools. The biomaterials were produced according to spec-
ifications for common implants for patients and all
bacterial species were isolated from implant infections of
patients in our clinic. Therefore, we believe these results
were representative and sterile maggot ES reduce not only
biofilms of P. aeruginosa [6] but also existing and mature
biofilms of S. aureus and S. epidermidis.
We observed biofilms were formed by all tested bacte-
rial species. These bacterial species were expected to form
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Fig. 4A–C These graphs compare the mean BF produced by S.
aureus with ES and the mean control BF after 8 days without ES and
answer the last research question whether ES reduced biofilms
produced by S. aureus. The 7-day-old biofilm was defined as 100%.
All values lower than the 8-day-old biofilm showed biofilm reduction.
(A) The biofilm on SSS was decreased for all concentrations with a
maximum of 59.5% for 0.31 lg ES per well. (B) The biofilm on PE
also was reduced for all concentrations with a maximum of 60.8% for
0.93 lg ES per well. (C) On TI, only 8.33 lg ES per well showed
biofilm reduction. *For these comparisons all p values \ 0.001; all
other comparisons were similar.
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Fig. 5A–C These graphs compare the mean BF produced by S.
epidermidis with ES and the mean control BF after 8 days without ES
and answer the last research question whether ES reduced biofilms
produced by S. epidermidis. The 7-day-old biofilm was defined as
100%. All values lower than the 8-day-old biofilm showed biofilm
reduction. (A) Biofilm on SSS was reduced for all concentrations with
a maximum of 67.7% for 25 lg ES per well. (B) Biofilm on PE also
was decreased for all concentrations with a maximum of 92.4% for
8.33 lg ES per well. (C) On TI, only 0.31 lg ES per well and 0.93 lg
ES per well showed biofilm reduction. *For these comparisons all p
values \ 0.001; all other comparisons were similar.
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biofilms, as they all were isolated from device-related
infections. The possible biofilm-forming capacities of the
five tested species on medical devices have been described
by others [4, 10, 20]. BF by K. oxytoca, E. faecalis, and E.
cloacae was insufficient to be quantified. Nutrient media
other than BHI were used to test BF by these bacteria but
did not show BF. The highest amount of biofilm was
formed by S. aureus and S. epidermidis, which are the most
frequently isolated pathogens from orthopaedic surgical
wounds [1].
BF between S. aureus and S. epidermidis were similar.
One study has compared the quantity among these two
bacterial species. Hudetz et al. [12] described equal BF but
a stronger adherence to material surfaces by S. epidermidis.
The quantity of BF depended on the biomaterial surface,
however published studies show differing results. Hudetz
et al. [12] found that the kind of metal, TI or SSS, plays a
minor role in the quantity of BF, whereas MacKintosh et al.
[16] reported biomaterial surface characteristics do influ-
ence BF. We found TI had the least amount of biofilm
in vitro formed by S. aureus and S. epidermidis. In a pre-
vious study, less biofilm was formed by P. aeruginosa on
SSS than on TI [6]. Therefore, we conclude that the
quantity of BF depends on the biomaterial and on the
bacterial specie creating the biofilm.
After 7 days of BF, the highest amount of biofilm was
formed. In the first 7 days, the nutrient medium in the
microtiter plate was not changed, because the biofilm
bacteria were still viable as the biofilm kept growing. New
nutrient medium with or without ES was added after 7 days
of incubation to maintain the viability of the bacteria. The
average time for biofilm maturation is 6 to 8 days [10, 22].
Although the 7-day-old biofilms in this study were not
examined by confocal microscopy, their maturation pro-
cess was more advanced than that of the previously tested
24-hour-old PAO1-biofilms which were decreased by ES
[6]. Thus, this research shows more evidence for the
therapeutic potential of ES for treatment against biofilm-
associated infections which involve mature biofilms.
The biofilm-decreasing capacity of maggot ES seems
optimal in low protein concentrations from 0.31 up to
8.33 lg ES per well (3.1 to 83.3 lg ES per mL). In pre-
vious studies, protein concentrations of as much as 20 lg
ES per well were reported as the most effective concen-
trations for biofilm reduction [6, 28]. There are several
possible explanations for the fact that the influence of ES at
higher concentrations than 20 lg ES per well declined [6].
We hypothesize a cofactor necessary to regulate the pro-
cess was depleted [17] or there is a nonenzymatic
interaction. In future studies concentration ranges less than
0.31 lg ES per well will be tested to examine the lower
limit amount of ES causing biofilm reduction.
Previous research suggests maggot ES do not possess
direct bactericidal or bacteriostatic activity against plank-
tonic organisms [5]. Therefore, ES are not expected to
reduce biofilm by destroying the bacteria in the matrix.
However, the influence of ES on biofilm bacteria will be
investigated in future studies, by examination of total
viable counts of bacteria.
Maggot ES broke down existing biofilms, because all
measurements were lower than the control BF after 7 days.
However, they also seem to inhibit additional growth of BF
as ES reduced BF to less than 100% in the experiments
with a greater amount of biofilm on Day 8 compared with
Day 7 (Fig. 4A–B). Therefore, potential therapeutic use of
ES could be prevention or inhibition of BF, eg, flushing
surgical wounds before closing and treatment against
existing biofilm-associated infections, especially on
orthopaedic medical devices. Further research is necessary
to clarify the mechanism(s) of biofilm reduction by maggot
ES and identify the substance(s) in ES responsible for these
reductions.
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